Evidence map›Paper›PMID 36860548›Full record

ArticleFrontiers in toxicology2023

Cholesterol content regulates silica-induced lysosomal membrane permeability.

Matthew J Sydor, Rebekah L Kendall, Andrij Holian

Open access · goldAbstract read
In one paragraph

Article in Frontiers in toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Matthew J SydorCenter for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States.
Rebekah L KendallCenter for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States.
Andrij HolianCenter for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States.
University of Montana · USCenter for Environmental Health · US

Funding

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP30GM140963 · NIGMS · UNIVERSITY OF MONTANA · PI RYTER, KENDAL · 2021 to 2025
$6.9M
Role of particle surface functionalization in inflammationR01ES033533 · NIEHS · UNIVERSITY OF MONTANA · PI Andrij Holian · 2022 to 2026
$2.7M
Acquisition of a Nikon A1 confocal laser-scanning microscope with PicoQuant FCS & FLIM upgradeS10OD021806 · OD · UNIVERSITY OF MONTANA · PI ROSS, J B ALEXANDER · 2016 to 2016
$555k
BK potassium channel activity in cSiO2-induced lysosome membrane permeability and inflammationF31ES033562 · NIEHS · UNIVERSITY OF MONTANA · PI KENDALL, REBEKAH · 2021 to 2022
$77k
NIEHS NIH HHS F31 ES033562NIEHS NIH HHS R01 ES033533NIGMS NIH HHS P30 GM140963NIH HHS S10 OD021806
6 · The paper itself

Abstract

Inhalation of crystalline silica has been well documented to cause pulmonary inflammation and lung disease such as silicosis. Respirable silica particles deposit in the lungs and are phagocytosed by alveolar macrophages. Subsequently, phagocytosed silica remains undegraded within lysosomes causing lysosomal damage known as phagolysosomal membrane permeability (LMP). LMP can trigger the assembly of the NLRP3 inflammasome resulting in release of inflammatory cytokines that contribute to disease. In order to better understand the mechanisms of LMP this study used murine bone marrow derived macrophages (BMdM) as a cellular model to investigate the mechanism of silica-induced LMP. Reduction of lysosomal cholesterol in bone marrow derived macrophages with 18:1 phosphatidylglycerol (DOPG) liposome treatment increased silica-induced LMP and IL-1

Indexed as

inflammationlysosomemacrophagemembranesilica

Identifiers

PMID36860548
PMCPMC9969097
OpenAlexW4320494493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.